We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
Cap. Flow
-$4.97M
Cap. Flow %
-0.67%
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.17M
2
CSTM icon
Constellium
CSTM
+$2.67M
3
KTB icon
Kontoor Brands
KTB
+$2.5M
4
SMTC icon
Semtech
SMTC
+$2.34M
5
CXT icon
Crane NXT
CXT
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 16.38%
2 Industrials 16.37%
3 Technology 14.13%
4 Consumer Discretionary 10.96%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIG icon
976
Employers Holdings
EIG
$881M
$269K 0.04%
6,568
-5,696
-46% -$228K
WKC icon
977
World Kinect Corp
WKC
$1.9B
$269K 0.04%
+9,959
New +$276K
CHCT
978
Community Healthcare Trust
CHCT
$443M
$268K 0.04%
6,346
+1,473
+30% +$63.8K
CIVI
979
DELISTED
Civitas Resources
CIVI
$268K 0.04%
+4,484
New +$244K
ALDX icon
980
Aldeyra Therapeutics
ALDX
$91.7M
$266K 0.04%
59,934
-66,180
-52% -$264K
AQB icon
981
AquaBounty Technologies
AQB
$6.59M
$266K 0.04%
+7,109
New +$247K
CORT icon
982
Corcept Therapeutics
CORT
$12.3B
$266K 0.04%
+11,813
New +$251K
CUBE icon
983
CubeSmart
CUBE
$9.16B
$266K 0.04%
5,122
-1,406
-22% -$71.2K
PRGS icon
984
Progress Software
PRGS
$1.78B
$266K 0.04%
5,648
-3,026
-35% -$136K
ORTX
985
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$266K 0.04%
37,428
+3,552
+10% +$34.8K
SBRA icon
986
Sabra Healthcare REIT
SBRA
$5.27B
$265K 0.04%
17,825
-96,374
-84% -$1.32M
CRI icon
987
Carter's
CRI
$1.49B
$264K 0.04%
+2,875
New +$270K
LUV icon
988
Southwest Airlines
LUV
$22.1B
$264K 0.04%
+5,757
New +$253K
NET icon
989
Cloudflare
NET
$108B
$264K 0.04%
2,202
+414
+23% +$43.2K
CRMD icon
990
CorMedix
CRMD
$581M
$263K 0.04%
48,022
+13,469
+39% +$61.7K
HPP
991
Hudson Pacific Properties
HPP
$753M
$263K 0.04%
1,354
-3,513
-72% -$632K
TMHC
992
DELISTED
Taylor Morrison
TMHC
$263K 0.04%
+9,655
New +$294K
ACMR icon
993
ACM Research
ACMR
$5.74B
$262K 0.04%
12,678
-19,782
-61% -$498K
EFX icon
994
Equifax
EFX
$21.4B
$262K 0.04%
+1,104
New +$260K
KNTK icon
995
Kinetik
KNTK
$8.12B
$262K 0.04%
+8,052
New +$263K
LH icon
996
Labcorp
LH
$25.8B
$262K 0.04%
1,156
-178
-13% -$41.9K
PD icon
997
PagerDuty
PD
$907M
$262K 0.04%
+7,654
New +$246K
FSR
998
DELISTED
Fisker Inc.
FSR
$262K 0.04%
20,285
+1,231
+6% +$15.4K
AN icon
999
AutoNation
AN
$6.86B
$261K 0.04%
+2,616
New +$289K
DCH
1000
Dauch Corp
DCH
$1.57B
$261K 0.04%
+33,617
New +$287K

Similar funds

GSA Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
  • GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
  • GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
  • GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
  • GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
  • GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
  • GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.